RB
Highly rated in
31
conditions

Dr. Robert A. Brodsky

Johns Hopkins University
Baltimore, MD
Highly rated in
31
conditions
Specialties:Hematology | Oncology
Experience:34 Years
Age:60
Accepts:New PatientsMedicare
Highly rated in
31
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

    View 23 More Conditions +
    Check Dr. Robert A. Brodsky's experience treating your condition:
    About Dr. Robert A. Brodsky

    Robert Brodsky is a Hematologist and an Oncologist in Baltimore, Maryland. Brodsky has been practicing medicine for over 34 years and is highly rated in 31 conditions, according to our data. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Hemolysis, Anemia, and Bone Marrow Transplant. He is licensed to treat patients in Maryland. Brodsky is currently accepting new patients.

    His clinical research consists of co-authoring 183 peer reviewed articles and participating in 4 clinical trials in the past 15 years.

    Insurance

    MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Robert A. Brodsky it is best to call his office and ask if your insurance is accepted.

    Accepts Medicare

    Dr. Robert A. Brodsky accepts the following insurance:

    •  Ambetter
    •  CareFirst
    Locations
    600 N Wolfe St, Baltimore, MD 21287
    Background & Education
    Graduate Institution
    Hahnemann University College Of Medicine, 1989
    Specialties
    Hematology
    Oncology
    Licenses
    Internal Medicine in MD
    Hospital Affiliations
    The Johns Hopkins Hospital
    Johns Hopkins Bayview Medical Center
    Languages Spoken
    English
    Gender
    Male
    Clinical Research

    Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

    4 Clinical Trials
    A Phase 2 Open-label Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy
    Enrollment Status: Active, not recruiting
    Publish Date: August 17, 2022
    Intervention Type: Drug
    Study Drugs: DanicopanEculizumab
    Study Phase: Phase 2
    An Open Label, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL-2 as an Add-On to Standard of Care in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH).
    Enrollment Status: Completed
    Publish Date: January 08, 2021
    Intervention Type: Drug
    Study Phase: Phase 1
    Phase II Study of High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis
    Enrollment Status: Withdrawn
    Publish Date: September 26, 2018
    Intervention Type: Drug
    Study Phase: Phase 2
    A Phase II Trial of Myeloablative Conditioning and Transplantation of HLA-matched, Partially HLA-mismatched, HLA-haploidentical or Matched Unrelated (MUD) Bone Marrow for Patients With Refractory Severe Aplastic Anemia
    Enrollment Status: Terminated
    Publish Date: October 13, 2016
    Intervention Type: Procedure
    Study Phase: Phase 2
    View 3 Less Clinical Trials -
    183 Total Publications
    The role of the alternative pathway in paroxysmal nocturnal hemoglobinuria and emerging treatments.
    Journal: Expert review of clinical pharmacology
    Published: August 18, 2022
    Save this doctor for later
    Sign Up
    Looking for the best doctor for you?
    Start Here
    Is this your doctor?
    Find a second opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn more
    Similar Doctors
    AD
    Dr. Amy E. Dezern
    Hematology | Oncology
    Highly rated in
    30
    conditions
    Hematology
    Oncology

    Johns Hopkins Health System

    Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins

    Baltimore, MD 
     0.1 mi

    Amy Dezern is a Hematologist and an Oncologist in Baltimore, Maryland. Dezern has been practicing medicine for over 18 years and is highly rated in 30 conditions, according to our data. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Bone Marrow Aspiration. She is licensed to treat patients in Maryland. Dezern is currently accepting new patients.

    PL
    Dr. Panayotis P. Ledakis
    Oncology | Hematology Oncology | Hematology
    Highly rated in
    75
    conditions
    Oncology
    Hematology Oncology
    Hematology

    The Weinberg Center

    227 St Paul Pl, 
    Baltimore, MD 
     1.2 mi

    Panayotis Ledakis is an Oncologist and a Hematologist Oncology expert in Baltimore, Maryland. Ledakis has been practicing medicine for over 36 years and is highly rated in 75 conditions, according to our data. His top areas of expertise are Appendix Cancer, Pseudomyxoma Peritonei, Desmoplastic Small Round Cell Tumor, and Colorectal Cancer. He is licensed to treat patients in Maryland. Ledakis is currently accepting new patients.

    SL
    Dr. Sophie M. Lanzkron
    Hematology
    Highly rated in
    14
    conditions
    Hematology

    Johns Hopkins Health System

    The Johns Hopkins Hospital - Sheikh Zayed Tower

    1800 Orleans St, 
    Baltimore, MD 
     0.1 mi

    Sophie Lanzkron is a Hematologist in Baltimore, Maryland. Lanzkron has been practicing medicine for over 32 years and is highly rated in 14 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Tubal Ligation, and Bone Marrow Transplant. She is licensed to treat patients in Maryland. Lanzkron is currently accepting new patients.